The chemical class known as Arl14epl Activators comprises a diverse range of molecules designed to modulate the activity of the ADP-ribosylation factor-like 14 effector protein-like (Arl14epl), which is a member of the ADP-ribosylation factor (ARF) family of GTP-binding proteins. These activators interact with Arl14epl in various ways to enhance its GTP-bound state, which is the active form of the protein. The mechanisms by which these compounds activate Arl14epl can be direct, such as by binding to the protein and inducing a conformational change that stabilizes the active state, or indirect, where they modulate other cellular factors that in turn affect the activity of Arl14epl. Examples of direct activators include non-hydrolyzable analogs of GTP, such as GTPγS, which can bind to Arl14epl and mimic the GTP-bound state without being susceptible to hydrolysis, thereby maintaining the protein in an active form. On the other hand, indirect activators may include inhibitors of regulatory proteins or enzymes that normally downregulate Arl14epl's activity, thereby resulting in its enhanced function.
The chemical diversity within this class is vast, with molecules ranging from small organic compounds to larger biological molecules. These activators can possess varying affinities for Arl14epl and may differ in their selectivity, with some being highly specific for Arl14epl, while others may have broader effects on other members of the ARF family or related GTPases. Activators may also differ in their mechanism of action; some may mimic endogenous ligands or substrates, whereas others could act as allosteric modulators. The structural diversity of Arl14epl activators is mirrored by the wide array of biochemical interactions they can engage in, extending from the direct stabilization of GTP-binding to the modulation of protein-protein interactions that are critical for the regulation of Arl14epl function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
GTPγS is a non-hydrolyzable analog of GTP that binds and activates G proteins. ADP-ribosylation factor-like 14 effector protein-like (Arl14epl) is similar to ARF-like (Arl) proteins, which are small GTPases. Binding of GTPγS to Arl14epl would enhance its GTP-bound active state, promoting the protein's interaction with downstream effectors. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits ADP-ribosylation factor (ARF) guanine nucleotide exchange factors (GEFs), stabilizing the GDP-bound ARF proteins. Since Arl14epl shares homology with ARF, Brefeldin A can indirectly enhance the activity of Arl14epl by reducing the competition for GEFs, thereby promoting Arl14epl's GTP-bound form. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a Cdc42 GTPase inhibitor. By selectively inhibiting Cdc42, it can lead to an upregulation of compensatory pathways that involve other small GTPases, including Arl14epl, potentially enhancing the activity of Arl14epl through indirect pathway modulation. | ||||||
ZCL278 | 587841-73-4 | sc-507369 | 10 mg | $115.00 | ||
ZCL278 is a Cdc42 GTPase inhibitor that disrupts the interaction between Cdc42 and its GEF. This could result in the redirection of GEF activity towards other GTPases, such as Arl14epl, enhancing its GTP-bound active state. | ||||||
EHT 1864 | 754240-09-0 | sc-361175 sc-361175A | 10 mg 50 mg | $213.00 $889.00 | 12 | |
EHT 1864 is a Rac family small GTPase inhibitor. By inhibiting Rac GTPases, it may cause compensatory activation of other small GTPases through shared regulatory mechanisms, potentially enhancing the activity of Arl14epl. | ||||||
2-(Benzoylcarbamothioylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic Acid | 314042-01-8 | sc-503400 | 10 mg | $300.00 | ||
CID-1067700 is a pan-GTPase inhibitor that can lead to upregulation of small GTPases activity as a compensatory mechanism. Such upregulation may enhance the activity of Arl14epl by favoring its active GTP-bound state. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
SecinH3 is an inhibitor of cytohesins, which are ARF-GEFs. By inhibiting cytohesins, SecinH3 could increase the relative activity of other small GTPases like Arl14epl by reducing competition for these GEFs, enhancing the GTP-bound active state of Arl14epl. | ||||||